Abstract:Background: Gliomas, known for their complex and aggressive characteristics, are deeply influenced by the tumor microenvironment. Matrix metalloproteinases (MMPs) play a vital role in shaping this environment, presenting an opportunity for novel treatment strategies. Methods: We collected six bulk RNA datasets, one single-cell RNA sequencing (scRNA-seq) dataset, and gene sets related to Matrix Metalloproteinases (MMPs), Endothelial-Mesenchymal Transformation (EndMT), and sprouting angiogenesis. We computed enrichment scores using Gene Set Variation Analysis (GSVA) and Single-sample Gene Set Enrichment Analysis (ssGSEA). To analyze immune infiltration, we employed the CIBERSORT method. Data analysis techniques included the log-rank test, Cox regression, Kruskal-Wallis test, and Pearson correlation. For single-cell data, we utilized tools such as Seurat and CellChat for dimensionality reduction, clustering, and cell communication analysis. Results: 1. MMP14 was identified as an independent prognostic marker, highly expressed in myeloid cells in recurrent glioblastoma, highlighting these cells as functionally significant. 2. C-C Motif Chemokine Ligand (CCL) signaling from MMP14+ myeloid cells was identified as a critical immune regulatory pathway, with high C-C Motif Chemokine Receptor 1 (CCR1) expression correlating with increased M2 macrophage infiltration and PD-L1 expression. 3. Patients with high MMP14 expression showed better responses to bevacizumab combined chemotherapy. 4. Signaling pathways involving Visfatin, VEGF, and TGFb, emanating from myeloid cells, significantly impact endothelial cells. These pathways facilitate EndMT and angiogenesis in gliomas. 5. Nicotinamide Phosphoribosyltransferase (NAMPT) showed a strong link with angiogenesis and EndMT, and its association with chemotherapy resistance and differential sensitivity to bevacizumab was evident. Conclusions: MMP14+ myeloid cells are critical in promoting tumor angiogenesis via EndMT and in mediating immunosuppression through CCL signaling in glioblastoma. MMP14 and NAMPT serve as vital clinical indicators for selecting treatment regimens in recurrent glioma. The study suggests that a combined blockade of CCR1 and CD274 could be a promising therapeutic strategy.

Human Astrocytes Secrete Il-6 to Promote Glioma Migration and Invasion Through Upregulation of Cytomembrane Mmp14

IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines

Il-6 Augments The Invasiveness Of U87mg Human Glioblastoma Multiforme Cells Via Up-Regulation Of Mmp-2 And Fascin-1

Data from Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion

Supplementary Figure 3 from Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion

Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma

Particulate Matter Facilitates C6 Glioma Cells Activation and the Release of Inflammatory Factors Through MAPK and JAK2/STAT3 Pathways

Supplementary Methods, Figure Legends 1-3, Tables 1-4 from Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion

Malignant Gliomas Induce and Exploit Astrocytic Mesenchymal-Like Transition by Activating Canonical Wnt/β-catenin Signaling

Autocrine IL-8 Promotes F-actin Polymerization and Mediate Mesenchymal Transition Via ELMO1-NF-κB-Snail Signaling in Glioma

OS10.7.A Activation of the CCR8-ACP5 axis by human microglia/macrophage derived CCL18 promotes glioma growth

CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.

Upregulation of microRNA‐133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway

Aberrant Expression of Interleukin-1β and Inflammasome Activation in Human Malignant Gliomas

Glioblastoma Drives Protease-Independent Extracellular Matrix Invasion of Microglia

Interleukin-6 Induces an Epithelial-Mesenchymal Transition Phenotype in Human Adamantinomatous Craniopharyngioma Cells and Promotes Tumor Cell Migration

Migfilin Promotes Migration and Invasion in Glioma by Driving EGFR and MMP-2 Signalings: A Positive Feedback Loop Regulation.

M2 Macrophage-Derived Exosomal Micrornas Inhibit Cell Migration and Invasion in Gliomas Through PI3K/AKT/mTOR Signaling Pathway

Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma

IL-13 Receptor Α2 Stimulates Human Glioma Cell Growth and Metastasis Through the Src/PI3K/Akt/mTOR Signaling Pathway.

Identification of Molecular Pathways Facilitating Glioma Cell Invasion in Situ.